Till startsida
To content Read more about how we use cookies on gu.se

Hanna Gyllensten


Institutionen för vårdvetenskap och hälsa
Box 457, 40530 Göteborg
E-mail: hanna.gyllensten@gu.se

+46-(0)70-748 24 12

Research areas
Drug-related morbidity, drug safety, pharmacoepidemiology, pharmacoeconomics, public health.

Important publications
1. Gyllensten H, Hakkarainen KM, Jönsson AK, Andersson Sundell K, Hägg S, Rehnberg C, Carlsten A.
Modelling drug-related morbidity in Sweden using an expert panel of pharmacists'
Int J Clin Pharm. 2012 Aug;34(4):538-46.

2. Hakkarainen KM, Alström D, Hägg S, Carlsten A, Gyllensten H.*
Modelling drug-related morbidity in Sweden using an expert panel of physicians.
Eur J Clin Pharmacol. 2012 Sep;68(9):1309-19.

3. Gyllensten H, Jönsson AK, Rehnberg C, Carlsten A.
How are the costs of drug-related morbidity measured? a systematic literature review.
Drug Saf. 2012 Mar 1;35(3):207-19.

4. Gyllensten H, Rehnberg C, Jönsson AK, Petzold M, Carlsten A, Andersson Sundell K.
Cost-of-Illness of patient-reported Adverse Drug Events – A population-based cross-sectional survey. BMJ Open. 2013; 3(6): e002574.

5. Gyllensten H, Steen Carlsson K.
Nya läkemedel och läkemedelsrelaterad sjuklighet: Analysmöjligheter i svenska registerdata. SNS Studeförbundet Näringsliv och Samhälle 2013 (http://www.sns.se/forlag/sjukvardens-kvalitetsregister-behover-anvandas-battre).

Evidence-based public health, health economics, quantitative research methods, social pharmacy.

1. Previous work experience from community pharmacy, as in-hospital clinical pharmacist, and coordinator of the pharmacy programme, Gothenburg university.
2. Member of the DRUMS-project research group (DRUMS stands for Drug-related morbidity in Sweden) at the Nordic School of Public Health NHV since 2008.

Page Manager: Marie Andersson|Last update: 6/23/2015

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?